Published in Clin Res Cardiol on November 12, 2014
The impact of trans-catheter aortic valve replacement induced left-bundle branch block on cardiac reverse remodeling. J Cardiovasc Magn Reson (2017) 0.75
Conduction disturbances after transcatheter aortic valve implantation procedures - predictors and management. Postepy Kardiol Interwencyjnej (2016) 0.75
In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany. Clin Res Cardiol (2017) 0.75
Transcatheter aortic valve implantation in patients with a reduced left ventricular ejection fraction: a single-centre experience in 2000 patients (TAVIK Registry). Clin Res Cardiol (2017) 0.75
Fatal myocardial infarction due to pseudo aneurysm of the aortic annulus after TAVR. Clin Res Cardiol (2017) 0.75
Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol (2017) 0.75
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation (2012) 2.95
Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol (1985) 2.28
Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol (2010) 1.71
Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol (2012) 1.52
Survival in octogenarians undergoing cardiac resynchronization therapy compared to the general population. Pacing Clin Electrophysiol (2014) 1.44
Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention (2014) 1.21
Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv (2008) 1.21
Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J (2010) 1.06
Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol (2014) 1.04
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol (2013) 1.03
Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol (2013) 1.01
Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol (2009) 0.98
Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J (2011) 0.97
Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J (2009) 0.92
Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol (2011) 0.90
Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook. Cardiol Rev (2013) 0.90
Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol (2010) 0.89
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J (2013) 0.87
The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol (2013) 0.87
Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol (2014) 0.86
Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol (2010) 0.86
Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm (2014) 0.84
Acute and late outcomes of Transcatheter Aortic Valve Implantation (TAVI) for the treatment of severe symptomatic aortic stenosis in patients at high- and low-surgical risk. J Interv Cardiol (2012) 0.84
Worldwide TAVI registries: what have we learned? Clin Res Cardiol (2014) 0.84
New conduction abnormalities after TAVI--frequency and causes. Nat Rev Cardiol (2012) 0.83
Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv (2012) 0.83
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation (2013) 0.81
Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience. Int J Cardiol (2013) 0.80
Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. J Invasive Cardiol (2014) 0.80
Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol (2013) 0.80
Right ventricular apical pacing-induced left ventricular dyssynchrony is associated with a subsequent decline in ejection fraction. Heart Rhythm (2013) 0.78
Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol (2014) 0.76
The importance of avoiding unnecessary right ventricular pacing in clinical practice. World J Cardiol (2013) 0.76
The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2014) 0.76
[Cardiac resynchronization therapy in patients with heart failure: a 10-year experience]. Rev Med Chil (2013) 0.75
Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv (2013) 0.75
Valvular disease: implications of new-onset conduction abnormalities after TAVI. Nat Rev Cardiol (2014) 0.75
Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv (2014) 0.75
Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement. Interact Cardiovasc Thorac Surg (2013) 0.75
Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA (2006) 3.78
Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA (2005) 3.67
A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol (2004) 2.67
Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation (2005) 2.61
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol (2003) 2.53
A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace (2013) 2.19
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 2.10
Characterization of paroxysmal and persistent atrial fibrillation in the human left atrium during initiation and sustained episodes. J Cardiovasc Electrophysiol (2002) 2.04
Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation (2003) 1.96
Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation (2010) 1.91
Automatic 3D mapping of complex fractionated atrial electrograms (CFAE) in patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.84
Phrenic nerve injury after catheter ablation: should we worry about this complication? J Cardiovasc Electrophysiol (2006) 1.83
Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting. Eur Heart J (2004) 1.43
The German CPU Registry: comparison of troponin positive to troponin negative patients. Int J Cardiol (2013) 1.43
High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43
Catheter ablation of left atrial focal tachycardia guided by electroanatomic mapping and new insights into interatrial electrical conduction. Heart Rhythm (2005) 1.41
The Use of Echocardiography in Certified Chest Pain Units: Results from the German Chest Pain Unit Registry. Cardiology (2016) 1.41
Drug interactions with angiotensin receptor blockers. Expert Opin Drug Saf (2005) 1.41
Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost (2010) 1.41
Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry (2008) 1.37
Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg (2010) 1.32
Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace (2006) 1.29
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag (2009) 1.22
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2007) 1.22
Low-grade albuminuria and cardiovascular risk : what is the evidence? Clin Res Cardiol (2007) 1.16
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2008) 1.14
Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol (2003) 1.13
Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS). BMC Public Health (2008) 1.13
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Cardiovasc Diabetol (2007) 1.10
Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm (2005) 1.10
Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med (2004) 1.09
Transvenous cryoablation versus radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a prospective randomized pilot study. Eur Heart J (2004) 1.09
Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol (2010) 1.09
Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany. Dtsch Arztebl Int (2008) 1.06
Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol (2011) 1.05
Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry. BMC Endocr Disord (2012) 1.05
Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J (2003) 1.04
Acute and long-term results of slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia--an analysis of the predictive factors for arrhythmia recurrence. Pacing Clin Electrophysiol (2005) 1.03
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol (2013) 1.03
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). BMC Cancer (2008) 1.02
C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J (2004) 1.01
Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care. Dtsch Arztebl Int (2008) 1.00
Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation. Am J Cardiol (2007) 0.99
Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol (2010) 0.98
Radiofrequency ablation of complex fractionated atrial electrograms (CFAE): preferential sites of acute termination and regularization in paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.98
Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review. Cardiovasc Diabetol (2013) 0.97
Necessity for biatrial ablation to achieve bidirectional cavotricuspid isthmus conduction block in a patient following senning operation. J Cardiovasc Electrophysiol (2004) 0.97
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J (2009) 0.96
Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry". Clin Res Cardiol (2012) 0.95
Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry. Eur J Prev Cardiol (2011) 0.94
Inappropriate shock delivery due to interference between a washing machine and an implantable cardioverter defibrillator. J Interv Card Electrophysiol (2002) 0.94
Predictors of complications in therapeutic plasma exchange. J Clin Apher (2009) 0.94
Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens (2008) 0.94
Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens (2007) 0.94
Does electrogram guided substrate ablation add to the success of pulmonary vein isolation in patients with paroxysmal atrial fibrillation? A prospective, randomized study. J Cardiovasc Electrophysiol (2008) 0.94
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag (2007) 0.93
Blood pressure management in a cohort of hypertensive patients in Germany treated by cardiologists. Clin Res Cardiol (2011) 0.93
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol (2014) 0.91
Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry. Cardiovasc Diabetol (2011) 0.91
Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation. Europace (2008) 0.90
Pacemaker auto-interference by thoracic impedance measurement for the rate response function. Pacing Clin Electrophysiol (2005) 0.90
Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am J Cardiol (2003) 0.89
LocaLisa catheter navigation reduces fluoroscopy time and dosage in ablation of atrial flutter: a prospective randomized study. J Cardiovasc Electrophysiol (2003) 0.89
Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J (2009) 0.89
Wave-direction and conduction-velocity analysis from intracardiac electrograms--a single-shot technique. IEEE Trans Biomed Eng (2010) 0.89
Cardiac troponin I sense-antisense RNA duplexes in the myocardium. J Cell Biochem (2002) 0.89
The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS). Clin Res Cardiol (2008) 0.88
Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study. Vasc Health Risk Manag (2012) 0.88
Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial. Curr Diab Rep (2013) 0.88
Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges. Psychosom Med (2006) 0.88
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease. Future Cardiol (2007) 0.88
Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation (2002) 0.88
The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol (2013) 0.87
Vildagliptin , a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin. Expert Opin Pharmacother (2014) 0.87
Delineation of intra-atrial reentrant tachycardia circuits after mustard operation for transposition of the great arteries using biatrial electroanatomic mapping and entrainment mapping. J Cardiovasc Electrophysiol (2003) 0.87
Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol (2014) 0.86
Ectopic tachycardia originating from the superior vena cava. J Cardiovasc Electrophysiol (2002) 0.86
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure. Expert Opin Pharmacother (2011) 0.86
Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm (2006) 0.86
Psychophysiological correlates of peritraumatic dissociative responses in survivors of life-threatening cardiac events. Psychopathology (2002) 0.86
Angiotensin blockade to reduce microvascular damage in diabetes mellitus. Dtsch Arztebl Int (2009) 0.86
The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol (2009) 0.86